ATE332373T1 - Menschlisches il-1 epsilon dna und polypeptide - Google Patents

Menschlisches il-1 epsilon dna und polypeptide

Info

Publication number
ATE332373T1
ATE332373T1 AT99945085T AT99945085T ATE332373T1 AT E332373 T1 ATE332373 T1 AT E332373T1 AT 99945085 T AT99945085 T AT 99945085T AT 99945085 T AT99945085 T AT 99945085T AT E332373 T1 ATE332373 T1 AT E332373T1
Authority
AT
Austria
Prior art keywords
polypeptides
human
fragmented peptides
epsilone
dna
Prior art date
Application number
AT99945085T
Other languages
English (en)
Inventor
John E Sims
Dirk E Smith
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE332373T1 publication Critical patent/ATE332373T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99945085T 1998-08-21 1999-08-20 Menschlisches il-1 epsilon dna und polypeptide ATE332373T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9741398P 1998-08-21 1998-08-21
US9859598P 1998-08-31 1998-08-31
US9997498P 1998-09-11 1998-09-11

Publications (1)

Publication Number Publication Date
ATE332373T1 true ATE332373T1 (de) 2006-07-15

Family

ID=27378375

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99945085T ATE332373T1 (de) 1998-08-21 1999-08-20 Menschlisches il-1 epsilon dna und polypeptide

Country Status (13)

Country Link
US (1) US7659375B2 (de)
EP (1) EP1105485B1 (de)
JP (1) JP4444506B2 (de)
AT (1) ATE332373T1 (de)
AU (1) AU756913B2 (de)
CA (1) CA2340790C (de)
CY (1) CY1105226T1 (de)
DE (1) DE69932247T2 (de)
DK (1) DK1105485T3 (de)
ES (1) ES2263285T3 (de)
NZ (1) NZ510497A (de)
PT (1) PT1105485E (de)
WO (1) WO2000011174A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU756913B2 (en) 1998-08-21 2003-01-23 Immunex Corporation Human IL-1 epsilon DNA and polypeptides
EP1239870A1 (de) * 1999-12-10 2002-09-18 Amgen Inc., Interleukin-1-rezeptor-antagonisten-ähnliche moleküle und deren verwendung
US8710014B2 (en) 2010-10-08 2014-04-29 Proteapex Therapeutics Llc Compositions and methods for inhibition of MMP13:MMP-substrate interactions
BR112021010374A2 (pt) 2018-12-21 2021-08-24 23Andme, Inc. Anticorpos anti-il-36 e métodos de uso dos mesmos

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4486530A (en) * 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4411993A (en) * 1981-04-29 1983-10-25 Steven Gillis Hybridoma antibody which inhibits interleukin 2 activity
NZ201705A (en) 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
US4737462A (en) * 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4543439A (en) * 1982-12-13 1985-09-24 Massachusetts Institute Of Technology Production and use of monoclonal antibodies to phosphotyrosine-containing proteins
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4902614A (en) * 1984-12-03 1990-02-20 Teijin Limited Monoclonal antibody to human protein C
US5071972A (en) * 1986-01-31 1991-12-10 Genetics Institute, Inc. DNA sequences encoding novel thrombolytic proteins
GB8628398D0 (en) * 1986-11-27 1986-12-31 Central Blood Lab Authority Pharmaceutically-active conjugates
US5011912A (en) * 1986-12-19 1991-04-30 Immunex Corporation Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
US4965195A (en) * 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4968607A (en) * 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
CA1340772C (en) 1987-12-30 1999-09-28 Patricia Tekamp-Olson Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
CA2049028A1 (en) 1989-03-07 1990-09-08 Genentech, Inc. Covalent conjugates of lipid and oligonucleotide
JP3205331B2 (ja) * 1989-03-14 2001-09-04 和光純薬工業株式会社 アクロモバクタープロテアーゼｉ類遺伝子及びその遺伝子産物
WO1990013641A1 (en) 1989-05-10 1990-11-15 Sloan-Kettering Institute For Cancer Research Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter
WO1991004753A1 (en) 1989-10-02 1991-04-18 Cetus Corporation Conjugates of antisense oligonucleotides and therapeutic uses thereof
KR920702409A (ko) 1989-10-24 1992-09-04 원본미기재 새로운 결합을 갖는 올리고뉴클레오티드 유사체
AU651596B2 (en) 1990-06-05 1994-07-28 Immunex Corporation Type II interleukin-1 receptors
US5350683A (en) * 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
US5262522A (en) * 1991-11-22 1993-11-16 Immunex Corporation Receptor for oncostatin M and leukemia inhibitory factor
US5449758A (en) * 1993-12-02 1995-09-12 Life Technologies, Inc. Protein size marker ladder
US5783672A (en) * 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M
US5863769A (en) * 1997-01-28 1999-01-26 Smithkline Beecham Corporation DNA encoding interleukin-1 receptor antagonist (IL-1raβ)
US6197551B1 (en) * 1998-01-27 2001-03-06 Millennium Pharmaceuticals, Inc. Spoil-1 protein and nucleic acid molecules and uses therefor
AU7103198A (en) * 1997-04-21 1998-11-13 Schering Corporation Mammalian cytokines; related reagents and methods
WO1999035268A1 (en) 1998-01-09 1999-07-15 Immunex Corporation IL-1 delta DNA AND POLYPEPTIDES
AU756913B2 (en) 1998-08-21 2003-01-23 Immunex Corporation Human IL-1 epsilon DNA and polypeptides

Also Published As

Publication number Publication date
JP4444506B2 (ja) 2010-03-31
AU756913B2 (en) 2003-01-23
CA2340790C (en) 2012-07-10
JP2002523046A (ja) 2002-07-30
NZ510497A (en) 2003-09-26
EP1105485B1 (de) 2006-07-05
WO2000011174A1 (en) 2000-03-02
DE69932247T2 (de) 2007-05-31
ES2263285T3 (es) 2006-12-01
DK1105485T3 (da) 2006-10-30
DE69932247D1 (de) 2006-08-17
AU5777799A (en) 2000-03-14
CA2340790A1 (en) 2000-03-02
US7659375B2 (en) 2010-02-09
US20080108796A1 (en) 2008-05-08
EP1105485A1 (de) 2001-06-13
CY1105226T1 (el) 2010-03-03
PT1105485E (pt) 2006-11-30

Similar Documents

Publication Publication Date Title
DK1129190T3 (da) Human TSLP DNA og polypeptider
DE69926480D1 (de) Acpl dna und polypeptide
ATE305510T1 (de) Zelloberflächenglycoproteinen zusammenhang mit menschlicher b zell lymphomen - ulbp, dns und polypeptiden
DE60132075D1 (de) Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren
HUP0004639A2 (hu) Chlamydia fehérje, génszekvencia és ezek alkalmazása
CY1107594T1 (el) DNA ΚΑΙ ΠΟΛΥΠΕΠΤΙΔΙΑ IL-1η
CY1105226T1 (el) Dna και πολυπεπτιδια il-1 εψιλον ανθρωπου
CY1105405T1 (el) Dna και πολυπεπτιδια il-1ζ, παραλλαγων ματισματος il-1ζ και xrec2
WO2000008180A3 (en) HUMAN cDNAs ENCODING POLYPEPTIDES HAVING KINASE FUNCTIONS
WO1999041388A3 (en) Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides
DE60031414D1 (de) Einkettige polypeptide enthaltend n-terminale troponin i fragmente und troponin c
WO1999031256A3 (en) Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis
WO2000008178A3 (en) Murine dna molecules encoding polypeptides having kinase functions
NZ505866A (en) V196 (also known as RAMP2) DNA and polypeptides
WO2001055211A3 (en) Fil-1 theta dnas and polypeptides
NZ503852A (en) Death associated kinase containing ankyrin repeats (DAKAR)
HIRAKAWA Structural protein analysis of intracisternal A particles in adenovirus-induced mouse tumor
EP1690871A3 (de) Xrec2 DNS und Polypeptide
WO2002077193A8 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1105485

Country of ref document: EP